Skip to content

Madakku Karisalai Thailam for Mandharakasam (Bronchitis)

Preclinical and Clinical Evaluation of Siddha herbal formulation Madakku Karisalai Thailam in Mandharakasam (Chronic Bronchitis)

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/026018
Enrollment
30
Registered
2020-06-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J410- Simple chronic bronchitis Health Condition 2: J410- Simple chronic bronchitis

Interventions

Intervention1: Madakku Karisalai Thailam: Dosage: 3 ml two times a day Duration: 48 days through oral route of administration Control Intervention1: NIL: NIL

Sponsors

National Institute of Siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: New patients with a clinical symptoms of sneezing, Rhinitis,Dyspnea,Cough with or without expectoration,wheeze,tightness of chest. FEV1/FVC-60% to 80% Wheezing more than three weeks Smoking history more than 1 year(10 packs/day) Patient who are willing to take radiological investigation and provide blood for lab investigation Patient who are willing to estimate volume of air forcibly expired after a deep inspiration by using Pulmonary funtion test

Exclusion criteria

Exclusion criteria: Cardiac disease Restrictive lung disease Renal disease Tuberculosis Status asthmaticus Lung carcinoma and other carcinomas Diabetic mellitus Hypertension Pregnancy Lactation Psychological factor Worm infestation Diagnosis of chronic sinusitis with allergic rhinitis Upper respiratory tract infection within last 6 weeks

Design outcomes

Primary

MeasureTime frame
Primary outcome is assessed by comparing the lung volumes and capacities in pre and post treatment pulmonary function testTimepoint: sixteenth day

Secondary

MeasureTime frame
Secondary outcome is assessed by comparing clinical signs and symptoms, laboratory parameters of IgE, AEC before and after treatmentTimepoint: Sixteenth day

Countries

India

Contacts

Public ContactDr Neethiraja M

National Institute of Siddha

dr.h.nalinisofia@gmail.com8939899363

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026